UK investing in 3 clinical trials to find a cure against COVID-19
Category: #health  By Pankaj Singh  Date: 2020-05-07
  • share
  • Twitter
  • Facebook
  • LinkedIn

UK investing in 3 clinical trials to find a cure against COVID-19

While numerous countries are currently working to find a cure for the COVID-19 outbreak, no drug trial has been able to clinically prove that it can treat the coronavirus yet. To further help this global mission of finding a cure, the UK Government has reportedly announced that it is funding three major clinical trials across the nation.

Reports cite that all three trials are assessing drugs other than remdesivir, which has already gone through clinical trials conducted by the United States and China.

Among the three trials, the clinical study conducted by researchers at Oxford University, in collaboration with UK hospital doctors, named the Recovery trial, is presently the largest clinical trial in the world that is looking for potential treatment options. The clinical trial is testing numerous drugs on pre-critical adult coronavirus patients that have been hospitalized in the UK.

Now underway with over 9,000 coronavirus adult patients across more than 130 NHS hospitals, researchers are testing if any new or existing drug, a combination of tablets and injections, could help those patients tackle this disease. Outcomes on whether the treatments are effective and safe are scheduled to arrive in five to seven weeks, which would potentially benefit millions of coronavirus patients across the world.

A senior government advisor of the United Kingdom government stated that Recovery is a key trial that is similar in design and concept to that of the WHO’s ‘Solidarity’ international clinical study to treat coronavirus patients, except remdesivir is not a part of it.

Apart from this key trial, other UK trials include Principle trial and the Remap-Cap trial. Principle trial is also being conducted by the Oxford University for people above the age of 65 and 50 having underlying health issues and are also showing COVID-19 symptoms. Meanwhile, the Remap-Cap trial is also being conducted in 12 other nations, and is particularly focused on critically sick COVID-19 patients that are in ICUs.

 

Source credit: https://timesofindia.indiatimes.com/world/uk/uk-is-funding-three-major-covid-19-clinical-trials-in-race-for-cure/articleshow/75585618.cms

 

 



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
Pfizer’s XALKORI®) Approved by US FDA for ALK-positive ALCL treatment
By Pankaj Singh

The pharma giant Pfizer Inc. has reportedly declared that the U.S. Food and Drug Administration (US FDA) has approved the sNDA (supplemental New Drug Application) for XALKORI® (crizotinib) for the treatment of chil...

JCB unites with ACI Worldwide to boost merchant acquiring capabilities
JCB unites with ACI Worldwide to boost merchant acquiring capabilities
By Pankaj Singh

JCB International, a credit card company, has reportedly partnered with ACI Worldwide, a payment system company, to increase merchant acquiring capabilities across the globe.

The To...

Wide occurrence of aortic stenosis to boost transcatheter aortic valve replacement demand
Wide occurrence of aortic stenosis to boost transcatheter aortic valve replacement demand
By Pankaj Singh

Research and development in the global transcatheter heart valve replacement industry have been gathering pace in recent years, with the increasing occurrence of valvular heart diseases and the demand for less invasive...